Clarification of Orphan Designation of Drugs and Biologics for Pediatric Subpopulations of Common Diseases: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 19, 2017
April 11, 2024
254d968c-50ac-46d1-9627-0b4e065111ba
Related Documents
End-of-Phase 2A Meetings
Guidance DocumentSeptember 18, 2009Center for Drug Evaluation and Research
Self-Selection Studies for Nonprescription Drug Products
Guidance DocumentApril 11, 2013Center for Drug Evaluation and Research
Time and Extent Applications for Nonprescription Drug Products
Guidance DocumentSeptember 29, 2011Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.